Viewing Study NCT02398214


Ignite Creation Date: 2025-12-18 @ 9:56 AM
Ignite Modification Date: 2025-12-18 @ 9:56 AM
Study NCT ID: NCT02398214
Status: None
Last Update Posted: 2017-04-18 00:00:00
First Post: 2015-03-08 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Sleep Hygiene-based Intervention Program for Infants and Toddlers
Sponsor: None
Organization:

Study Overview

Official Title: A Sleep Hygiene-based Intervention Program for Infants and Toddlers
Status: None
Status Verified Date: 2016-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Sleep problems are reported in 71.65% of our nation's infants and toddlers, and the prevalence is much higher than the 20-30% reported in Western countries. The investigators' preliminary findings also show that approximately 53-55% of parents of children between 6 and 12 months of age consider their child sleep a problem with about 4% not knowing whether their child sleep is a problem. Sleep development during infancy is characterized by increasing day-night differences in sleep-wakefulness such as longer bouts of sleep and fewer awakenings at night, and is driven by neurobiological maturation and environmental interactions. By 3 months of age, nearly 58% of infants can sleep continuously between 24:00-05:00 hours. When infants do not sleep through the night by 17 months of age, they are less likely to be able to do so at 29 months of age and beyond. Without proper intervention, sleep problems during infancy can persist to toddler and preschool age. Various interventions have been developed and tested in Western and Asian Countries to address the sleep problems in infants and young children, but none are in Taiwan.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: